GWCM
RXII

Godshalk Welsh Capital Management’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Godshalk Welsh Capital Management’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,000
Closed -$2K – 280
2014
Q4 		$2K Buy
+1,000
New +$2K ﹤0.01% 282

Other funds holding RXII

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Godshalk Welsh Capital Management's RXII Position: Q1 2015 in Review

Godshalk Welsh Capital Management sold out of GALENA BIOPHARMA INC COM (RXII) in Q1 2015, closing a stake of 1,000 shares — an estimated $2K sold.

Godshalk Welsh Capital Management first reported a position in RXII in Q4 2014 and held it in 1 quarter. The position peaked at $2K in Q4 2014. 87 funds tracked by Wall St. Rank hold RXII as of Q1 2015.

  • Godshalk Welsh Capital Management reported no remaining GALENA BIOPHARMA INC COM position as of Q1 2015 after selling out during the quarter.
  • Godshalk Welsh Capital Management sold 1,000 GALENA BIOPHARMA INC COM shares in Q1 2015, an estimated $2K.
  • Godshalk Welsh Capital Management first reported a position in GALENA BIOPHARMA INC COM in Q4 2014 and held it in 1 quarter.
  • Godshalk Welsh Capital Management's GALENA BIOPHARMA INC COM position peaked at $2K in Q4 2014.
  • 87 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q1 2015.

Based on Godshalk Welsh Capital Management's 13F filing for Q1 2015, filed 12 May 2015.